An interesting bioethics debate

Does early detection work? __The New York Times__ today posts a linkurl:story about Claudia Henschke,;http://www.nytimes.com/2006/10/31/health/31prof.html a radiology professor at Weill Cornell Medical College who?s pushing for routine CT scans to detect lung cancer earlier. The phrases are so well trodden, they?re often taken at face value: ?We?re lucky we caught it in time,? or ?If only we?d found it sooner.? The problem with simply accepting that earlier detection means better survival i

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Does early detection work? __The New York Times__ today posts a linkurl:story about Claudia Henschke,;http://www.nytimes.com/2006/10/31/health/31prof.html a radiology professor at Weill Cornell Medical College who?s pushing for routine CT scans to detect lung cancer earlier. The phrases are so well trodden, they?re often taken at face value: ?We?re lucky we caught it in time,? or ?If only we?d found it sooner.? The problem with simply accepting that earlier detection means better survival is that it?s largely just an assumption. Yes, evidence strongly suggests that colonoscopy prevents death from colon cancer. But colon cancer and lung cancer are different. All cancers are different. To make a recommendation of routine screening, surely there should be some data showing that it doesn?t 1) raise false alarms over small but benign tumors or 2) miss fast growing, aggressive tumors that may be responsible for most cancer deaths. We?ll have more on this in November as Emanuel Petricoin and Lance Liotta square off against Barnett Kramer on using proteomics as a method for early detection. The Times? wrote a linkurl:front page story;http://www.nytimes.com/2006/10/26/health/26lung.html on Henschke?s recent uncontrolled study in __New England Journal of Medicine__ just last week. Today?s story paints Henschke as a bit of a maverick and details her frustration with what the writer calls a wet blanket statement from the ACS and the NCI: ?needs more research.? Would a controlled study limit access to a lifesaving technique? Would the technique even be cutting edge at the end of the study? Would it merely result in more dangerous surgeries and biopsies for harmless tumors. It?s an interesting debate on the nature of scientific research, and its gold standard to test every hypothesis, meeting head on with medicines? do-no-harm tenet.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies